The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.

Researchers found that specific metabolites of resveratrol in urine accurately reflect red wine consumption. These biomarkers ...

The global axial spondyloarthritis market is set for significant growth, with forecasts indicating a robust CAGR of 14.8% during the period from 2022 to 2028. This growth is primarily attributed to ...

The report delivers a comprehensive analysis of global biologics sales. Covering cancer antibodies, non-TNF inflammatory mAbs, biosimilars, gene therapy, RNA-based drugs, and more, the report provides ...

Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.17. Operator: Thank you for standing by. My name is ...

Now the time has finally come: Bluetooth 6.0 is just around the corner. Read on to find out what’s in it for you and what capabilities the developers have given the new wireless standard.

Reported positive six-month data from ADVANCED-2 trial of TARA-002 in patients with NMIBC; Announcement of initial data from 12-month evaluable patients expected by mid-2025 Dosing of first patient in ...

2 Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology RAS, Moscow, Russian Federation Objectives Neutralisation of tumour necrosis ...